Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis

Open Access

Peer-reviewed

Research Article

Xulei Tang ,

Contributed equally to this work with: Xulei Tang, Lin Yang

* E-mail: xulei_tang@126.com

Affiliation Department of Endocrinology, the First Hospital of Lanzhou University, Lanzhou, Gansu, China
⨯
Lin Yang ,

Contributed equally to this work with: Xulei Tang, Lin Yang

Affiliation Department of Endocrinology, the First Hospital of Lanzhou University, Lanzhou, Gansu, China
⨯
Zhiyu He,

Affiliation Department of Internal Medicine, the First Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China
⨯
Jingfang Liu

Affiliation Department of Endocrinology, the First Hospital of Lanzhou University, Lanzhou, Gansu, China
⨯

Reader Comments (0)

Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Bladder cancer
Is the Subject Area "Bladder cancer" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.